For some overweight patients trying to lose weight, the biggest obstacle is not motivation.

It is pain.

A familiar situation:

You want to lose weight.

You know movement helps.

But:

• knee pain makes walking difficult
• back pain worsens after activity
• sciatica interrupts exercise
• hip pain limits stairs
• painful joints repeatedly derail progress

This creates a practical question:

“If pain is stopping me from exercising, could injections help me move again?”

For selected patients, this may be a reasonable question.

But the answer depends heavily on diagnosis, suitability, and treatment goals.

---

Why Pain Can Block Weight Loss Progress

Weight management advice often assumes movement is practical.

But if walking or exercise repeatedly causes pain, patients often:

• reduce activity
• avoid movement
• lose confidence
• stop exercise attempts
• gain weight
• experience worsening joint or spine loading

This creates:

Pain → less movement → deconditioning → weight gain → greater loading → more pain

This can be difficult to break without a more practical plan.

---

When Pain Is The Immediate Barrier

Some patients know exactly what the issue is:

“I would exercise if it didn’t hurt so much.”

Examples:

• painful knee osteoarthritis
• severe flare-ups after walking
• spine-related symptoms with standing
• sciatica limiting movement
• painful hip loading
• recurrent activity-related pain

For these patients, reducing the pain barrier may become an important practical step.

---

What Are Joint Or Spine Injection-Based Pathways?

For selected patients, clinicians may sometimes consider injection-based options as part of broader musculoskeletal management.

Examples may include selected pathways involving:

Joint-Based Injection Pathways

Depending on diagnosis and suitability:

• knee-related injection pathways
• hip-related injection pathways
• other selected joint-based pathways

---

Spine-Related Injection Pathways

Depending on diagnosis and suitability:

• selected spine-related injection pathways
• symptom-targeted procedural pathways where clinically appropriate

---

These are clinical tools—not universal solutions.

---

What Is The Practical Goal?

For selected patients, the practical goal may be:

not simply short-term symptom reduction—

but restoring enough function to allow broader rehabilitation.

That may include helping selected patients:

• walk more comfortably
• participate in physiotherapy
• rebuild movement confidence
• tolerate rehabilitation progression
• reduce fear of movement
• re-engage in activity

---

Important Limitations

Injection-based pathways are not suitable for everyone.

They do not automatically:

• fix the underlying diagnosis
• restore strength
• correct gait dysfunction
• resolve poor movement mechanics
• replace rehabilitation
• create sustainable long-term function by themselves

This distinction matters.

---

Why Diagnosis Matters First

The practical question is not:

“Should I get an injection?”

It is:

“Why does movement hurt?”

Potential contributors may include:

• knee osteoarthritis
• meniscal irritation
• tendon overload
• spinal stenosis
• disc-related symptoms
• sciatica
• hip pain
• gait dysfunction
• lower limb biomechanical overload

Different contributors may require different strategies.

---

Why Diagnostic Clarity Matters

Depending on the clinical question, evaluation may involve:

• medical assessment
• physiotherapy assessment
• gait analysis
• movement evaluation
• X-ray where clinically appropriate
• ultrasound where clinically appropriate
• MRI where clinically appropriate

The goal is not routine testing.

The goal is choosing appropriate information to guide practical decisions.

---

Where Do GLP-1 And Medical Weight Management Fit?

For selected overweight or obese patients, physician-supervised prescription medical weight management may also be relevant.

This may include:

GLP-1 Receptor Agonist Pathways

These involve prescription pathways acting through the:

glucagon-like peptide-1 (GLP-1) receptor

Potential formulations may include:

• self-administered injectable prescription pathways
• oral GLP-1 receptor agonist pathways where medically appropriate

These may potentially support:

• appetite regulation
• reduced caloric intake
• structured weight reduction efforts

---

Dual GIP / GLP-1 Receptor Agonist Pathways

For selected patients, newer incretin-based prescription pathways involving:

• glucose-dependent insulinotropic polypeptide (GIP)
  and
• glucagon-like peptide-1 (GLP-1)

may also be considered.

---

Other Oral Prescription Anti-Obesity Medication Pathways

Depending on suitability, other prescription anti-obesity medication categories may also be considered.

---

Important:

medical weight management supports weight reduction—

but does not automatically solve painful movement mechanics.

---

Why Physiotherapy Still Matters

Even if pain is reduced, rehabilitation remains highly relevant.

Support may include:

• coordinated physiotherapy rehabilitation
• neuromuscular rehabilitation
• movement retraining
• gait retraining
• progressive strengthening
• walking tolerance rebuilding
• lower limb loading progression

Pain reduction without rehabilitation often creates incomplete recovery.

---

Education Matters Too

Patients often benefit from understanding:

• what is driving symptoms
• realistic expectations
• pacing
• flare-up management
• progression planning
• self-management strategies

---

Who May Fit This Type Of Pathway?

Examples:

Overweight patients who:

• want to lose weight
• repeatedly fail exercise because pain flares
• have painful knees, hips, or spine symptoms
• would participate more if pain were better controlled
• need a more practical rehabilitation entry point

---

Shared Decision-Making Matters

Not every patient needs:

• injections
• prescription medical weight management
• imaging
• rehabilitation

Appropriate decisions depend on:

• diagnosis
• symptom severity
• medical suitability
• treatment goals
• practical barriers

---

Key Takeaway

For selected patients whose painful joints or spine symptoms make exercise unrealistic, clinically appropriate injection-based pathways may sometimes help reduce barriers to rehabilitation.

But injections are usually best viewed as one component of a broader practical strategy—not a standalone solution.

---

About Dr Terence Tan And The Pain Relief Clinic

Dr Terence Tan has highlighted a practical issue commonly seen in overweight patients:

sometimes the first challenge is not “how do I lose weight?”—it is “how do I move enough to begin?”

The Pain Relief Clinic provides doctor-led musculoskeletal assessment, coordinated rehabilitation planning, diagnostic clarity where clinically appropriate, patient education support, and physician-supervised medical weight management pathways for selected patients.

Clinic Location:
350 Orchard Road
#10-00 Shaw House
Singapore 238868